Summary
Updated Aug 31, 2026
Arun Swaminathan is Chief Executive Officer of Coya Therapeutics, Inc. (COYA). 3 SEC Form 4 filings on record going back to 2024, most recently on 26 January 2026. Most recent open-market trade: bought $37K of COYA on 13 November 2024. Lifetime open-market purchases: $73K.
Recent Transactions
2Every recent SEC Form 4 transaction Arun Swaminathan has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Arun Swaminathan. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fred Grossman - $20K of COYA open-market activity on record
- David S. Snyder - $13K of COYA open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Arun Swaminathan?
Arun Swaminathan is a corporate insider, tracked as Chief Executive Officer of Coya Therapeutics, Inc. (COYA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Arun Swaminathan last file a Form 4?
The most recent primary Form 4 on record is dated 26 January 2026, one of 3 filings going back to 2024.
Has Arun Swaminathan been buying or selling stock?
Recorded transactions: 2 open-market purchases ($73K) and 0 open-market sales across all tracked filings.
Where can I see all of Arun Swaminathan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Arun Swaminathan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
